Position in ZTS
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$2,329,919
-$78,149 QoQ
Shares Held
19,710
+3.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
13 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Derivatives in ZTS
reported options exposure · as of Jun 30, 2025CallValue
$951,295
CallShares
6,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Jefferies Financial Group Inc. holds $32,795,534 across 16 Drug Manufacturers - Specialty & Generic names. ZTS ranks #4 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
507,909 | $15,481,066 | |
| 2 | PCRX |
Pacira BioSciences, Inc.
|
196,292 | $4,436,199 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
6,001 | $3,558,472 | |
| 4 | ZTS |
Zoetis Inc.
This page
|
19,710 | $2,329,919 | |
| 5 | ANIK |
Anika Therapeutics, Inc.
|
93,500 | $1,355,750 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
31,564 | $950,707 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
12,000 | $922,800 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
24,300 | $803,601 |
All Filings in ZTS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,329,919 | 19,710 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $2,408,068 | 19,139 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $588,352 | 4,021 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $951,295 | 6,100 | Call | Defined | 2025-08-12 | |
| 2025-06-30 | $7,634,844 | 48,957 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,185,480 | 7,200 | Call | Defined | 2025-05-08 | |
| 2025-03-31 | $6,300,990 | 38,269 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $2,709,200 | 16,628 | Shares | Defined | 2025-02-27 | |
| 2024-09-30 | $60,410,714 | 309,196 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $20,896,467 | 120,538 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,271,167 | 19,332 | Shares | Defined | 2024-05-13 | |
| 2023-09-30 | $767,599 | 4,412 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,894,310 | 11,000 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,077,780 | 24,500 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,535,315 | 17,300 | Shares | Defined | 2023-09-21 | |
| No filing history on record for this holder in this stock. | ||||||